Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss
Unless the price of ZEC rallies, Cypherpunk Technologies says it will need to raise a lot of money to pay for its upcoming FDA trials.
Unless the price of ZEC rallies, Cypherpunk Technologies says it will need to raise a lot of money to pay for its upcoming FDA trials.
A stock price crash canceled SpaceX insiders’ $80B bonus unlock, and almost nobody in financial media noticed.
Crypto.com slashed cardholder rewards while customers’ CRO stayed locked and a multi-billion dollar Trump-affiliated deal collapsed.
Two weeks after BitMart promised withdrawals would remain available, users say the exchange is dragging its feet.
On-chain evidence suggests that HTX has transferred a portion of its reserves to the Justin Sun-owned Poloniex exchange.